HAHilmi Furkan Arslan

Hilmi Furkan Arslan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hilmi Furkan Arslan has a total of 39 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Nesfatin-1 levels and non-suicidal self-injury in adolescents with major depressive disorder: a cross-sectional study

    by Bedia Sultan Onal, Hilmi Furkan Arslan, Cansu Cobanoglu Osmanlı, Berkan Sahin, Gülsüm Yitik Tonkaz

    Background: Non-suicidal self-injury (NSSI) is a deliberate, repetitive act resulting in tissue damage without suicidal intent and is frequently associated with depressive disorders. Nesfatin-1, an anorexigenic peptide expressed in the hypothalamus, has been implicated in stress-related psychopathologies beyond its metabolic functions. This study aimed to investigate the relationship between serum nesfatin-1 levels and non-suicidal self-injury in adolescents diagnosed with major depressive disorder (MDD). Methods: This study included 40 adolescents aged 12–18 years with MDD, 41 adolescents with MDD and comorbid NSSI, and 45 healthy controls. All participants were medication-free for at least eight weeks prior to enrollment. Psychiatric diagnoses were established using K-SADS-PL. Depressive symptom severity and self-injurious behaviors were assessed using the CDI and ISAS, respectively. Serum nesfatin-1 levels were measured using a sandwich enzyme-linked immunosorbent assay (ELISA). Results: Serum nesfatin-1 levels differed significantly among the three groups ( p < 0.001) and were highest in the MDD+NSSI group. Both patient groups exhibited significantly higher nesfatin-1 levels than healthy controls, and the MDD+NSSI group showed significantly higher levels than the MDD group ( p = 0.010), despite comparable depressive symptom severity between the two patient groups. Serum nesfatin-1 levels were positively correlated with depressive symptom severity (Spearman’s ρ = 0.691, p < 0.001). ROC curve analyses demonstrated good discriminative ability of nesfatin-1 for distinguishing patient groups from healthy controls and fair discriminative ability for differentiating adolescents with MDD+NSSI from those with MDD alone (AUC = 0.671, 95% CI: 0.553–0.789, p = 0.008). CDI scores did not differ between the two patient groups ( p = 0.059) despite both being significantly higher than those of the control group ( p < 0.001). Conclusions: Serum nesfatin-1 levels were associated with both depressive symptom severity and NSSI in adolescents with MDD. Notably, nesfatin-1 levels differentiated adolescents with MDD+NSSI from those with MDD alone despite comparable depressive symptom severity between the two patient groups. These findings suggest that nesfatin-1 may be involved in neurobiological processes underlying self-injurious behavior in adolescent depression. Future longitudinal studies with larger samples are needed to further clarify the role and clinical relevance of nesfatin-1 in adolescents with depression and NSSI. Trial registration: Not applicable.

  • Open Access

    Biochemical, cardiac, and neuroimaging correlates of pediatric carbon monoxide poisoning: a single-source mass exposure study

    by Handan Ayhan Akoğlu, Muhammet Bulut, Gökhan Tonkaz, Hilmi Furkan Arslan, Emine Tekin, Bekir Yükcü

    Aims: To evaluate the association between fractional carboxyhemoglobin (FCOHb) levels and biochemical markers of poisoning severity, and to describe cardiac and neuroimaging findings in a pediatric cohort affected by a single-source mass carbon monoxide (CO) exposure.Methods: This retrospective cross-sectional study included pediatric patients exposed during a single-source mass CO exposure event. Of 64 screened patients, 6 were excluded from inferential analyses because their initial FCOHb levels were

  • Open Access

    Systemic endothelial activation and eosinophilic inflammation in pediatric allergic rhinitis: diagnostic value of endocan and eosinophil-derived neurotoxin

    by Handan Ayhan Akoğlu, Hilmi Furkan Arslan, Mahmut Doğru

    Objective biomarkers that reflect systemic inflammation in pediatric allergic rhinitis to support clinical diagnosis. We aimed to evaluate serum levels of endocan (a marker of endothelial activation) and eosinophil-derived neurotoxin (EDN; reflecting eosinophil degranulation) in children with AR and investigate their diagnostic performance and associations with disease severity and conventional inflammatory markers. In this prospective case-control study, 85 children with AR and 67 healthy controls were enrolled. Serum endocan and EDN were measured via sandwich ELISA. Primary outcomes included group comparisons of biomarker levels and their diagnostic accuracy determined by receiver operating characteristic (ROC) curve analysis. Serum endocan and EDN levels were significantly elevated in children with AR compared to controls (both p < 0.001). Both biomarkers demonstrated high diagnostic performance, with an area under the curve (AUC) of 0.931 for endocan and 0.929 for EDN, showing greater diagnostic accuracy than absolute eosinophil counts (AUC, 0.871). Endocan and EDN showed a strong intercorrelation (r = 0.88, p < 0.001) and significant positive correlations with total IgE and eosinophil counts. However, no significant associations were observed between these biomarkers and disease severity, symptom control scores, or allergen sensitization patterns. Conclusions : Serum endocan and EDN are significantly elevated in children with AR and demonstrate high diagnostic discrimination in this cohort. These findings suggest that endocan and EDN may serve as promising complementary biomarkers for the objective assessment of allergic inflammation in children, although further multicenter studies are needed to confirm their clinical utility. What's Known: • Allergic rhinitis (AR) is common in childhood and involves systemic inflammatory pathways; however, objective biomarkers to support diagnosis in pediatric practice remain limited. • Endocan and eosinophil-derived neurotoxin (EDN) reflect endothelial activation and eosinophil degranulation, respectively, and have been studied in other atopic and inflammatory conditions. What is New: • This study concurrently evaluates serum Endocan and EDN in children with AR in a prospective case–control design. • Both biomarkers demonstrated high discriminatory performance (AUC∼ 0.93 in this cohort) and showed greater diagnostic accuracy than absolute eosinophil counts . • Endocan and EDN are largely independent of generalized systemic inflammatory indices (NLR, SII, SIRI), supporting specificity for the endothelial— eosinophilic axis in pediatric AR.


  • Open Access

    Unveiling hepatic involvement in de novo preeclampsia; In light of FIB-4 index and APRI

    by Hilmi Furkan Arslan, Mehmet Albayrak

    Preeclampsia often affects multiple organ systems, including the liver. Noninvasive markers such as the fibrosis-4 (FIB-4) index and aspartate aminotransferase to platelet ratio index (APRI) are frequently employed to evaluate liver fibrosis in chronic liver diseases. The objective of this research was to examine the alterations in FIB-4 index and APRI in newly developed preeclampsia and evaluate their diagnostic capability in identifying liver involvement. This retrospective cross-sectional investigation, spanning from 2018 to 2024, was carried out at Giresun Obstetrics and Pediatrics Training and Research Hospital. The study involved 198 women with de novo preeclampsia and 195 healthy pregnant women serving as a control group. The researchers compared laboratory findings and maternal-fetal outcomes between these 2 cohorts. Both APRI and FIB-4 indices were found to be significantly elevated in the de novo preeclampsia group when compared to controls ( P < .001). For predicting de novo preeclampsia, the optimal threshold for APRI was established at 0.24 (sensitivity 62.1%, specificity 61.4%), while for FIB-4 it was determined to be 0.65 (sensitivity 67.2%, specificity 78.5%). The area under curve values for these indices did not differ significantly. Regression analysis indicated that both APRI and FIB-4 indices were significantly linked to de novo preeclampsia. This study suggests that APRI and FIB-4 may be useful as noninvasive tools for detecting liver dysfunction in preeclampsia cases. However, further extensive prospective studies are required to validate these observations and determine standardized cutoff values for routine clinical use.


  • Open Access

    Neurosteroids, Anxiety and Quality of Life in Acromegaly

    by Burcu Hacioglu, Sebnem Burhan, Hilmi Furkan Arslan, Ozlem Balci, Aysenur Ozderya, Mehmet Emin Pişkinpaşa, Mutlu Niyazoglu, Esra Hatipoglu

    Objective: Acromegaly reduces quality of life. Neurosteroids can impact neuropsychological status and anxiety, but their effects on anxiety in acromegaly cases and quality of life are unclear. This study aims to evaluate the relationship between neurosteroids, anxiety, and quality of life in acromegaly patients. Design: This study included 33 cases in the acromegaly group (AG) and 30 healthy subjects in the control group (CG). Beck Anxiety Inventory (BAI) and Short Form-36 (SF-36) were used to assess anxiety levels and Quality of Life (QoL), respectively. The research assessed how anxiety and quality of life scores correlate with the concentrations of growth hormone, IGF-1, and specific neurosteroids (Allopregnanolone (AP), pregnenolone (PRG), 24S-hydroxycholesterol (24OHC), dehydroepiandrosterone (DHEA), dehydroepiandrosterone sulfate (DHEAS), androsterone (ADT)). Results: AG had significantly higher BAI scores in comparison to CG. The SF-36 subdomain scores of general health, physical functioning, role limitations due to physical health, energy/fatigue, emotional well-being, social functioning, and pain were significantly lower in the AG. Conclusion: Neurosteroids may affect the quality of life and be associated with depression and anxiety levels in acromegaly.

  • Open Access

    Useful Biomarkers for Preeclampsia: Evaluating the Diagnostic Potential of FIB-4 and FIB-5 Indices

    by Mehmet Albayrak, Hilmi Furkan Arslan

    Background/Objectives: Preeclampsia is a systemic condition that can result in liver impairment and potentially lead to negative outcomes for both the mother and baby. Various indices have been created to facilitate the early detection of liver issues. Among these, the Fibrosis-4 index (FIB-4) and Fibrosis-5 index (FIB-5) have been utilized for several years to forecast liver dysfunction. In our research, we aimed to apply these indices to patients with preeclampsia for the first time. Methods: This retrospective study, conducted at Giresun University from 2017 to 2024, included 207 patients with preeclampsia and 205 healthy controls. Data on maternal age, BMI, obstetric history, delivery method, gestational age, birth weight, and Apgar scores were extracted from medical records for analysis and biochemical parameters. Data were analyzed statistically. Results: The study found that FIB-4 index values were significantly higher and FIB-5 index values were lower in preeclampsia patients compared to the controls. FIB-4 demonstrated a better diagnostic performance with higher sensitivity and specificity. Although the difference between the two indices was not statistically significant, both were independently predictive of preeclampsia. The correlation coefficient showed that FIB-4 was positively correlated with spot urine protein/creatinine ratio (SPCR) and aspartate aminotransferase (AST), while FIB-5 was negatively correlated with these parameters and with alkaline phosphatase. Conclusions: This study found that FIB-4 and FIB-5 are useful for predicting preeclampsia, with FIB-4 showing superior diagnostic performance. These findings highlight their potential in the early detection and management of preeclampsia. Further research is needed for clinical validation.


  • Open Access

    New systemic inflammatory indices as predictors of ascending aortic dilation in children with bicuspid aortic valve: A retrospective cross-sectional study

    by Bekir Yükcü, Hilmi Furkan Arslan

    Systemic inflammatory indices, originally developed to predict the prognosis of cancer patients, have found increasing application in various medical areas, including cardiovascular research. This study aimed to investigate the relationship between ascending aortic dilatation in bicuspid aortic valve patients and systemic inflammatory indices. This retrospective cross-sectional study included 122 patients with bicuspid aortic valves. These patients were divided into 2 groups based on the presence or absence of dilatation according to ascending aorta z-scores. Complete blood counts were analyzed, focusing on leukocyte, neutrophil, lymphocyte, monocyte, and platelet counts. Additionally, systemic inflammatory indices including neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio (PLR), Systemic Immune-Inflammation Index (SII), Systemic Inflammatory Response Index (SIRI), and monocyte-to-lymphocyte ratio (MLR) and pan-immune-inflammation value (PIV) were calculated from these parameters. MLR, SIRI, and PIV demonstrated acceptable diagnostic power in detecting ascending aortic dilatation in bicuspid aortic valve patients, with area under the curve (AUC) values of 0.709, 0.741, and 0.779, respectively. PLR and SII exhibited fair diagnostic power, with AUC values of 0.673 and 0.688, respectively. According to the receiver operating characteristic analysis, PIV had the highest AUC value of 0.779 (95% confidence interval [CI] = 0.69–0.86), with a sensitivity of 70.9% and specificity of 70.8% at a cutoff value of 224.93. A relationship exists between PLR, MLR, SII, SIRI, PIV, and ascending aorta dilatation in pediatric patients with bicuspid aortic valves. These findings suggest that inflammation may play a role in the dilatation of the ascending aorta in bicuspid aortic valve patients.


  • Open Access

    Tıbbi Laboratuvarlarda Risk Yönetimi Kılavuzu

    by Derya Sönmez, Soycan Mızrak, Ayla Yıldız, Bağnu Orhan, Hilmi Furkan Arslan, Hikmet Can Çubukçu, Canan Karadağ, Alper Gümüş, Cihan Coşkun, Habib Özdemir, et al.

    Risk Yönetimi Süreci ve Risk Yönetimi Planı Derya SÖNMEZ Risk Değerlendirme Soycan MIZRAK Risk Kontrolü ve Risk İzleme Ayla YILDIZ Risk-Fayda Analizi ve Risk Yönetimini Gözden Geçirme Bağnu ORHAN Bazı Risk Analizi Teknikleri, Hata Türleri ve Etkileri Analizi Hilmi Furkan ARSLAN Hata Raporlama ve Düzeltici Faaliyet Sistemi Hikmet Can ÇUBUKÇU Kalite Yönetim Sistemi Açısından Risk Yönetimi Uygulamaları Canan KARADAĞ Risk Yönetimine Dayalı Kalite Kontrol Uygulamaları Alper GÜMÜŞ Biyokimya Laboratuvarında Hata Türleri ve Etkileri Analizi Uygulaması Cihan COŞKUN Tam Kan Sayımı Laboratuvarında Hata Raporlama ve Düzeltici Faaliyet Sistemi Uygulaması Habib ÖZDEMIR Glukoz Testi İçin Risk Yönetimine Dayalı Kalite Kontrol Planı Oğuzhan ZENGI

  • Open Access

    Evaluation of the implementation of the rational use of laboratory tests in the clinical chemistry laboratory

    by Huriye Serin, Bagnu Orhan, Merve S. Say, Hilmi F. Arslan, Sinemis Inal, Berrin B. Inal, Mehmet Senes

    Objectives: The ‘Rational Laboratory Use Project’ (RLUP) was launched in 2018 by the Department of Examination and Diagnosis Services under the General Directorate of Health Services of the Republic of Turkey’s Ministry of Health. In this study, we aimed to determine the rate of implementation of RLUP in medical biochemistry laboratories, and to contribute to new regulations by collecting the information and opinions of the laboratory experts participating the survey. Methods: Thirty questions were uploaded to an online survey tool (SurveyMonkey ® , San Mateo, ABD). The first five were descriptive for laboratories. Among the remaining 25 questions, one is open-ended and addresses the various topics encompassed by the project’s scope. Results: The questionnaire was completed by 202 medical biochemistry specialists, of whom 82.12 % reported that they did not implement autoverification. 55.65 % defined consultations in Hospital Management Information System (HIMS), but; 70.49 % were not using it actively. 57.69 % of the participants answered, “I agree” to the statement “I think RLUP is feasible”. It was observed that the specialists tried to implement rational laboratory practices partially depending on their laboratory capacity, hospital administration and Laboratory Information Management System (LIMS). Conclusions: Increasing clinicians’ awareness could increase the success of this project, which might provide more effective diagnosis and treatment for the patient. In our view, actively involving stakeholders of the information management system, which is not under the direct control of laboratory professionals, in the RLUP will accelerate the development of the project.